# Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy

> **NCT00760955** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 338 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** TAK-583
- **DRUG:** TAK-583
- **DRUG:** TAK-583
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00760955
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760955, "Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00760955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*